(Press-News.org) BOSTON -- Epithelial ovarian cancer is the most lethal cancer of the female reproductive organs, with more than 200,000 new cases and more than 125,000 deaths each year worldwide. Because symptoms tend to be vague, 80 percent of these cancers are not recognized until the disease has advanced and spread to other parts of the body. The standard treatment for advanced ovarian cancer includes high-dose chemotherapy, which often results in debilitating side effects and for which the five-year survival rate is only 35 percent.
Now new research in an animal model finds that a novel combination therapy, which couples low-dose chemotherapy with an antiangiogenic treatment, resulted in better survival rates compared with standard therapy. Led by investigators at Beth Israel Deaconess Medical Center (BIDMC) and the University of Guelph, the findings show that the agent, 3TSR, not only led to tumor regression, but also improved tumor blood flow and enabled more efficient delivery of much smaller and less toxic doses of chemotherapy.
The study currently appears online in The Journal of the Federation of American Societies for Experimental Biology (FASEB) and will be published in the February 2015 print issue.
"The five-year survival rate for ovarian cancer has changed very little over the past 20 years and new treatment options are urgently needed, "says co-senior author Jack Lawler, PhD, an investigator in BIDMC's Center for Vascular Biology Research and Professor of Pathology at Harvard Medical School. "High dose chemotherapy is usually required for the treatment of advanced ovarian cancer because the vascular supply to the tumor is inefficient and the cells inside the tumor have limited exposure to the chemotherapy drugs. Our results showed that when pretreated with an antiangiogenic agent, the animals responded to smaller, more frequent doses of chemotherapy, while still deriving more clinical benefit compared to current therapy protocols."
Like many other types of cancer, ovarian cancer obtains nutrients and oxygen by inducing the growth of new blood vessels, a process known as angiogenesis. Antiangiogenic approaches to treat cancers attempt to disrupt the balance between promoters and inhibitors of angiogenesis, either by inhibiting proangiogenic factors or by increasing antiangiogenic molecules.
The Lawler laboratory at BIDMC investigates thrombospondin-1 (TSP-1), the first naturally occurring protein to be identified as an angiogenesis inhibitor. "What we're trying to do is to boost the antiangiogenic side of the balance in order to deprive the tumor of blood supply and halt growth," he says.
Previous work by Lawler and others had revealed that a portion of TSP-1 known as 3TSR interacts with another protein, CD36, which is found on the surface of endothelial cells that line the blood vessels. Together, the two molecules cause endothelial cells to stop growing and die, reducing blood vessel growth and disrupting the tumor's ability to survive. The new findings revealed that 3TSR was acting on more than just endothelial cells and was directly inhibiting growth of ovarian tumor cells. "We think this might be occurring because, like endothelial cells, ovarian cancer cells contain CD36," says Lawler. "The sensitivity of the tumor cells to 3TSR means that both endothelial and tumor cells can be targeted with a single reagent."
Many of the blood vessels in tumors don't function properly to distribute blood because they are not correctly formed; these blood vessels are destroyed during the early phase of antiangiogenic treatment, resulting in a period of time when blood flow to the tumor improves. In this new paper, Lawler, and co-senior author Jim Petrik, PhD, of the University of Guelph, wanted to find out if 3TSR would enhance uptake of chemotherapy drugs delivered through lower-dose "metronomic" regimen.
They conducted a series of experiments in which mouse ovarian cancer cells were injected into an animal model and allowed to grow until they exhibited features similar to patients with advanced disease, namely the spread of small tumors throughout the abdomen and the accumulation of fluid called ascites.
"This is the advanced stage at which most women are first diagnosed with ovarian cancer," explains Lawler. The investigators then treated the mice with either intermittent doses of standard high-dose chemotherapy or with more frequent doses of low-dose chemotherapy. In each case, the chemotherapy was either administered on its own or in combination with pretreatment with 3TSR.
The end result for the pretreated mice receiving the smaller chemotherapy doses was a smaller tumor, with improved blood supply. "We were able to exploit this enhanced blood supply to improve chemotherapy drug delivery to the tumor, with excellent clinical effect," adds Lawler. "The benefit of this approach is that we can create an environment that increases the efficiency of drug delivery, enabling the use of significantly lower doses of the chemotherapeutic agents and thereby reducing the side effects associated with the treatment."
"The clinical implications are significant," he adds. "With this approach, patients could receive significantly smaller doses of chemotherapy drug while deriving greater clinical benefit, compared to current therapy protocols. We hope that this will soon be tested in clinical trials."
INFORMATION:
In addition to Lawler and Petrik, coauthors include Mark Duquette, of Massachusetts General Hospital who conducted this work while at BIDMC; Samantha Russell of University of Guelph, Ontario, Canada; and Joyce Liu and Ronny Drapkin of the Dana-Farber Cancer Institute.
This study was funded by National Institutes of Health grants CA130895 and NS077797, as well as grants from the Canadian Institutes for Health Research and Ovarian Cancer Canada and a CAO Pilot Grant from BIDMC.
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and currently ranks third in National Institutes of Health funding among independent hospitals nationwide.
BIDMC is in the community with Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth Israel Deaconess Hospital-Plymouth, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, Signature Healthcare, Beth Israel Deaconess HealthCare, Community Care Alliance, and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Senior Life and is a research partner of Dana-Farber/Harvard Cancer Center and The Jackson Laboratory. BIDMC is the official hospital of the Boston Red Sox. For more information, visit http://www.bidmc.org.
CORVALLIS, Ore. - Researchers from Oregon State University and other institutions have developed a new biomarker called "SDMA" that can provide earlier identification of chronic kidney disease in cats, which is one of the leading causes of their death.
A new test based on this biomarker, when commercialized, should help pet owners and their veterinarians watch for this problem through periodic checkups, and treat it with diet or other therapies to help add months or years to their pet's life.
Special diets have been shown to slow the progression of this disease once ...
RIVERSIDE, Calif. - How do galaxies like our Milky Way form, and just how do they evolve? Are galaxies affected by their surrounding environment? An international team of researchers, led by astronomers at the University of California, Riverside, proposes some answers.
The researchers highlight the role of the "cosmic web" - a large-scale web-like structure comprised of galaxies - on the evolution of galaxies that took place in the distant universe, a few billion years after the Big Bang. In their paper, published Nov. 20 in the Astrophysical Journal, they present observations ...
BOSTON (Nov. 20, 2014) Investigators at Massachusetts Eye and Ear and Harvard Medical School Department of Ophthalmology and colleagues reported the development and characterization of a comprehensive genetic test for inherited eye disorders in the online version of the Nature journal Genetics In Medicine today. The Genetic Eye Disease (GEDi) test includes all of the genes known to harbor mutations that cause inherited retinal degenerations, optic atrophy and early onset glaucoma. These disorders are important causes of vision loss, and genetic treatments such as gene ...
DURHAM, N.C. -- Displaced political aides looking for a new, nonpartisan job in the wake of the midterm power shuffle may fare better if they tone down any political references on their resumes, finds a new study from Duke University.
The study found that applicants who shared the minority partisan view of voters where a resume was sent were less likely to receive a callback from an employer than a candidate with a neutral resume.
Sharing information in line with the majority partisan view didn't give candidates an advantage, however.
"Our results showed that individuals ...
A new study from UNC's Frank Porter Graham Child Development Institute (FPG) reveals that disruptions in child care negatively affect children's social development as early as age 4. However, the study also shows that the effects of child care instability are not unduly large--and some types of instability appear to have no negative impact on children.
"Our findings showed that when young children moved between child care settings, these transitions negatively affected their social adjustment," said FPG investigator Mary Bratsch-Hines. "But when children had a history ...
The research found that incisor teeth grow quickly in the early stages of the second trimester of a baby's development, while molars grow at a slower rate in the third trimester. This is so incisors are ready to erupt after birth, at approximately six months of age, when a baby makes the transition from breast-feeding to weaning.
Weaning in humans takes place relatively early compared to some primates, such as chimpanzees. As a result, there is less time available for human incisors to form, so the enamel grows rapidly to compensate.
This research can increase our understanding ...
New Rochelle, NY, November 20, 2014-Women are more sensitive to the effects of cocaine and more susceptible to cocaine abuse than men. Cocaine's ability to disrupt a woman's estrus cycle may explain the sex differences in cocaine addiction, and new evidence that caffeine may be neuroprotective and able to block cocaine's direct effects on the estrus cycle reveals novel treatment possibilities, according to an article published in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, ...
Birds that are related, such as Darwin's finches, but that vary in beak size and behavior specially evolved to their habitat are examples of a process called speciation. It has long been thought that dramatic changes in a landscape like the formation of the Andes Mountain range or the Amazon River is the main driver that initiates species to diverge. However, a recent study shows that speciation occurred much later than these dramatic geographical changes. Researchers from LSU's Museum of Natural Science have found that time and a species' ability to move play greater parts ...
The higher your level of education, the greater your earnings and your sense of "personal mastery" or being in control of your fate, University of Toronto researchers say. But wait: there's a downside.
Professor Scott Schieman, Canada Research Chair in the Social Contexts of Health, and PhD student Atsushi Narisada investigated the adverse effects associated with attaining a high degree of mastery. Using the Canadian Work, Stress, and Health Study (CANWSH), a national sample of Canadian workers, the researchers measured proficiency, or mastery, by asking study participants ...
Thanks to the NASA/ESA Hubble Space Telescope, some of the most mysterious cosmic residents have just become even more puzzling. New observations of globular clusters in a small galaxy show they are very similar to those found in the Milky Way, and so must have formed in a similar way. One of the leading theories on how these clusters form predicts that globular clusters should only be found nestled in among large quantities of old stars. But these old stars, though rife in the Milky Way, are not present in this small galaxy, and so, the mystery deepens.
Globular clusters ...
